Bringing Health Innovation to the next level
Health Innovation Netherlands (HI-NL) is based on the proven fact that early dialogue between innovators and relevant stakeholders improves the value and effectiveness of health innovations. By bringing all relevant innovators and stakeholders together in one place through the HI-NL Track, comprehensive well-structured guidance can be provided to accelerate the introduction of innovations that directly meet end-user needs.
HI-NL Track
The Health Innovation Netherlands (HI-NL) Track offers innovators in the medical technology space early insight into the path they need to follow in order to successfully bring their idea to the market.
latest news
-
Successful HI-NL case team meeting
Yesterday HI-NL organized a HI-NL case team meeting with useful insights, clear updates, and good exchange between members from several HI-NL case teams. The discussions and great energy once again showed the value of sharing experiences across case teams. -
HI-NL wishes you happy holidays and an innovative 2026!
As 2025 comes to a close, we look back on another impactful year for Health Innovation Netherlands (HI-NL), marked by strong collaboration, insightful discussions, and a shared commitment to advancing Medtech innovation. -
Interview with innovator Egbert Smit (MLA Diagnostics)
We recently interviewed Egbert Smit, CEO of MLA Diagnostics. Five years ago, MLA Diagnostics started developing an innovative risk assessment test for skin cancer.